What We Do

Frederick Health Biobank

With support from the Hurwitz Breast Cancer Fund, Frederick Health’s Biobank is shaping the future of cancer care:

Advancing cancer research with a sustainable supply of high-quality specimens.
Making personalized treatments possible for every patient.
Promoting health equity by driving treatment breakthroughs that benefit diverse populations affected by cancer.
Building a legacy of healing and hope—the knowledge gained from biobank specimens donated today will become tomorrow’s cures.

The Frederick Health Biobank was made possible, in part, through the generosity of the Hurwitz Breast Cancer Fund

The Galleri® Multi-Cancer Early Detection (MCED) test screens for over 50 types of cancer often missed in routine care.

With a safe, quick, and non-invasive blood test, this means:

Earlier diagnosis before cancers become symptomatic.
More information on the cancer’s origin, guiding next steps for treatment and care.
Increased accessibility to care.
Enhanced efforts towards reducing the 70% of deaths caused by cancers that currently don’t have recommended screenings.

Early diagnosis saves lives. Together, we are giving families across Maryland access to the latest technology in healthcare.

Availability of the Galleri ® test to our patients is made possible, in part, through the generosity of the Hurwitz Breast Cancer Fund

Assessed over 1,300 patients for genetic pre-dispositions to cancer.
Navigated 170 patients into a highrisk breast cancer surveillance program.
Screened 22 patients for cancer through Galleri® testing, a revolutionary blood test for cancer detection.
Enrolled 15 patients into breast cancer clinical trials.
Opened 3 breast cancer clinical trials.
Shaped the future of cancer detection through the storage of 17 blood samples in the Frederick Health Biobank.
Identified 138 patients who are eligible to donate to the Biobank.

A dedicated breast research nurse provides personalized clinical trial options.
23 clinical trials are currently open, with 9 trials specific to breast cancer*.
Over 800 patients have been screened in the past
year for clinical trial eligibility, with 500 of these screend for breast cancer trials*.

*Services made possible, in part, through the generosity of the Hurwitz Breast Cancer Fund.

The Galleri® Multi-Cancer Early Detection (MCED) test screens for over 50 types of cancer often missed in routine care.

With a safe, quick, and non-invasive blood test, this means:

Earlier diagnosis before cancers become symptomatic.
More information on the cancer’s origin, guiding next steps for treatment and care.
Increased accessibility to care.
Enhanced efforts towards reducing the 70% of deaths caused by cancers that currently don’t have recommended screenings.

Early diagnosis saves lives. Together, we are giving families across Maryland access to the latest technology in healthcare.

Availability of the Galleri® test to our patients is made possible, in part, through the generosity of the Hurwitz Breast Cancer Fund.

With support from the Hurwitz Breast Cancer Fund, Frederick Health’s Biobank is shaping the future of cancer care:

Advancing cancer research with a sustainable supply of high-quality specimens.
Making personalized treatments possible for every patient.
Promoting health equity by driving treatment breakthroughs that benefit diverse populations affected by cancer.
Building a legacy of healing and hope— the knowledge gained from biobank specimens donated today will become tomorrow’s cures.

The Frederick Health Biobank was made possible, in part, through the generosity of the Hurwitz Breast Cancer Fund.

To learn more about the Galleri® Multi-Cancer Early Detection test, scan this QR code with your smart phone or visit frederickhealth.org/galleri

galleri qr code